Y. Hu et al. / Tetrahedron: Asymmetry 14 (2003) 3907–3915
3913
(M++1) calcd for C46H38N2O4P 713.2564; found,
(s, 3H), 2.02–2.11 (m, 2H), 2.49–2.74 (m, 6H), 6.06 (d,
J=8.0 Hz, 1H), 6.76 (d, J=8.0 Hz, 1H), 6.83 (d, J=8.0
Hz, 1H), 7.00 (d, J=8.0 Hz, 1H), 7.06 (d, J=7.6 Hz,
1H), 7.18–7.30 (m, 4H), 7.39–7.46 (m, 2H), 7.57–7.61
(m, 2H), 7.87 (d, J=7.6 Hz, 1H), 7.96–8.02 (m, 2H),
8.12–8.18 (m, 2H), 9.09 (d, J=9.2 Hz, 1H), 10.16 (s,
1H); 13C NMR (CD2Cl2) l 22.88, 23.06, 23.87, 28.12,
29.52, 119.13, 119.22, 119.76, 120.28, 122.17, 122.24,
122.85, 125.30, 125.96, 126.04, 126.25, 127.19, 127.93,
128.66, 128.83, 129.53, 129.78, 130.04, 131.32, 132.00,
133.84, 134.17, 134.70, 135.66, 136.18, 137.83, 137.99,
138.98, 145.70, 146.06, 149.09, 149.32, 157.36, 162.15;
31P NMR l +136.87; HRMS (m/z): (M++1) calcd for
C47H40N2O4P 727.2720; found, 727.2703.
713.2590.
4.2.2.2. (S,S)-(+)-L2. Following the similar method
for the synthesis of L1, Ligand L2 (704.3 mg, 97%) was
prepared from amide 3b (411.0 mg, 1.0 mmol) and
(S)-MonoPhos (467.1 mg, 1.3 mmol) as a white foamy
1
solid: mp 211–212°C; [h]2D2=+173.5 (c 0.5, THF); H
NMR (CD2Cl2) l 1.63–1.75 (m, 8H), 2.18–2.45 (m,
7H), 2.85 (br. m, 4H), 6.70 (d, J=8.8 Hz, 1H), 7.10–
7.30 (m, 8H), 7.33–7.41 (m, 3H), 7.61 (t, J=7.6 Hz,
1H), 7.76 (d, J=8.8 Hz, 1H), 7.84–7.95 (m, 4H), 8.54
(d, J=8.4 Hz, 1H), 9.90 (s, 1H); 13C NMR (CD2Cl2) l
23.36, 23.48, 23.63, 24.06, 27.85, 28.50, 30.16, 117.02,
118.99, 119.14, 119.22, 122.20, 122.51, 123.05, 124.67,
125.38, 125.62, 126.02, 126.14, 126.53, 126.78, 127.05,
127.25, 128.24, 128.87, 129.89, 130.17, 130.82, 131.73,
132.10, 132.75, 133.20, 133.80, 134.71, 135.39, 136.57,
137.94, 138.66, 147.69, 148.07, 149.81, 157.37, 161.94;
31P NMR l +145.81; HRMS (m/z): (M++1) calcd for
C47H40N2O4P 727.2720; found, 727.2765.
4.2.2.5. (S,S)-(+)-L5. Following the same method for
the synthesis of L3, ligand L5 (510.0 mg, 64%) was
prepared from amide (S)-3a (437.9 mg, 1.1 mmol) and
1.4 mmol of (S)-H8-MonoPhos as a white foamy solid:
mp 170–712°C; [h]D22=+45.9 (c 0.5, THF); 1H NMR
(CD2Cl2) l 1.49–1.74 (m, 16H), 2.14–2.18 (m, 6H),
2.73–2.85 (m, 10H), 6.21 (d, J=8.4 Hz, 1H), 6.85–6.90
(m, 2H), 7.06 (t, J=8.0 Hz, 2H), 7.22 (d, J=8.0 Hz,
1H), 7.26–7.30 (m, 2H), 7.77 (t, J=7.6 Hz, 1H), 8.11
(d, J=8.0 Hz, 1H), 8.21 (d, J=4.8 Hz, 1H), 8.44 (d,
J=8.4 Hz, 1H), 9.65 (s, 1H); 13C NMR (CD2Cl2) l
23.16, 23.33, 23.56, 23.68, 23.85, 28.02, 28.41, 28.65,
29.79, 30.31, 30.38, 117.87, 119.30, 119.39, 119.54,
119.67, 122.38, 126.66, 126.94, 128.32, 129.79, 129.95,
129.99, 130.84, 134.24, 134.60, 134.84, 135.45, 135.79,
136.75, 138.05, 138.57, 139.16, 146.18, 146.59, 147.91,
148.00, 148.51, 150.96, 162.16; 31P NMR l +137.49;
HRMS (m/z): (M++1) calcd for C46H46N2O4P 721.3190;
found, 721.3175.
4.2.2.3. (S,S)-(+)-L3. (S)-H8-BINOL (353.2 mg, 1.2
mmol), hexamethylphosphorustriamide (244.5 mg, 1.5
mmol), 2.5 mg of NH4Cl and 5 ml of benzene were
added to a 25 ml air-free Schlenk flask equipped with a
reflux condenser under an argon atmosphere. The mix-
ture was refluxed for 12 h, then the reaction mixture
was filtered. The filtrate was concentrated under
reduced pressure. The residue in 15 ml toluene and
(S)-3c (346.4 mg, 0.89 mmol) were added to a new
dried 50 ml Schlenk flask under an argon atmosphere.
The mixture was heated to reflux. After the reaction
was complete (detected by TLC), the reation solution
was cooled. White precipitation occurred. The resulting
solid was collected by filtration under argon and
washed with toluene (2×2 ml) to afford 477.0 mg of
(S,S)-L3 as a white solid. The filtrate was purified by
flash chromatograghy on a silica gel column (eluted
with CH2Cl2) to afford another 110.0 mg of (S,S)-L3,
the yield was 92%: mp 282–285°C; [h]2D2=+60.3 (c 0.5,
4.2.2.6. (S,S)-(+)-L6. Following the same method for
the synthesis of L3, ligand L6 (589.3 mg, 80%) was
prepared from amide (S)-3b (412.0 mg, 1.0 mmol) and
1.4 mmol of (S)-H8-MonoPhos as a white foamy solid:
mp 264–267°C; [h]D22=+37.7 (c 0.5, THF); 1H NMR
(CD2Cl2) l 1.46–1.73 (m, 16H), 2.11–2.42 (m, 9H),
2.53–2.84 (m, 10H), 6.13 (d, J=8.0 Hz, 1H), 6.85 (t,
J=8.4 Hz, 2H), 7.05 (t, J=8.4 Hz, 2H), 7.14 (d, J=7.6
Hz, 1H), 7.21–7.26 (m, 2H), 7.64 (t, J=7.6 Hz, 1H),
7.88 (d, J=7.6 Hz, 1H), 8.49 (d, J=8.4 Hz, 1H), 9.88
(s, 1H); 13C NMR (CD2Cl2) l 22.94, 23.11, 23.37,
23.50, 23.65, 24.08, 27.81, 28.20, 28.49, 29.57, 30.15,
116.91, 118.98, 119.15, 119.30, 119.51, 126.02, 126.21,
128.08, 128.19, 129.57, 129.77, 130.75, 133.69, 134.58,
134.65, 135.14, 135.58, 136.42, 137.80, 137.96, 138.55,
138.97, 145.95, 146.40, 147.96, 149.90, 157.38, 161.88;
31P NMR l +137.53; HRMS (m/z): (M++1) calcd for
C47H48N2O4P 735.3346; found, 735.3307.
1
THF); H NMR (CD2Cl2) l 1.41–1.45 (m, 2H), 1.69–
1.70 (m, 6H), 2.05–2.12 (m, 2H), 2.52–2.80 (m, 6H),
6.17 (d, J=8.0 Hz, 1H), 6.80 (d, J=8.0 Hz, 1H), 6.86
(d, J=8.4 Hz, 1H), 7.02 (d, J=8.0 Hz, 1H), 7.15–7.29
(m, 5H), 7.40–7.46 (m, 2H), 7.61 (d, J=8.8 Hz, 1H),
7.72 (t, J=7.6 Hz, 1H), 7.97–8.02 (m, 3H), 8.11–8.20
(m, 3H), 9.03 (d, J=8.8 Hz, 1H), 9.96 (s, 1H); 13C
NMR (CD2Cl2) l 23.07, 23.26, 28.33, 29.74, 119.33,
119.47, 120.66, 121.22, 122.30, 122.37, 122.48, 123.00,
125.66, 126.16, 126.35, 126.83, 127.39, 128.08, 128.85,
129.04, 129.77, 130.01, 130.17, 131.57, 132.09, 134.03,
134.30, 134.91, 135.87, 136.18, 138.06, 139.18, 145.92,
146.25, 148.45, 149.21, 150.36, 162.47; 31P NMR l
+136.87; HRMS (m/z): (M++1) calcd for C46H38N2O4P
713.2564; found, 713.2544.
4.3. General procedure for asymmetric 1,4-conjugate
addition
4.2.2.4. (S,S)-(+)-L4. Following the same method for
the synthesis of L3, ligand L4 (694.7 mg, 80%) was
prepared from amide (S)-3d (485.0 mg, 1.2 mmol) and
1.4 mmol of (S)-H8-MonoPhos as a white foamy solid:
mp 243–245°C; [h]D22=+57.1 (c 0.5, THF); 1H NMR
(CD2Cl2) l 1.40–1.43 (m, 2H), 1.66–1.69 (m, 6H), 1.96
4.3.1. Preparation of the catalyst. L1 (71.2 mg, 0.10
mmol), 12.6 mg of [Cu(CH3CN)4]BF4 (0.04 mmol) and
10 ml of toluene were added to a 50 ml air-free Schlenk
flask under an argon atmosphere. After stirring 30 min
at room temperature, the solvent was stripped off in
vacuo, 8 ml of CH2Cl2 was added to the flask and the